Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology, November 2022
Volume46
Issue 11
Pages: 12

Microbubble-Enabled Isolation Kit

Akadeum’s Life Sciences isolation kit uses microbubbles to reduce leukopak production time.

Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation Kit

Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation Kit

Akadeum Life Sciences’ Microbubble Leukopak Human T-Cell Isolation kit is a research-use-only kit developed to address various biological and workflow challenges in large-volume cell separation workflows. The kit uses a technology combining microbubbles with a buoyancy-activated cell sorting separation tube to produce nearly two leukopaks,which are blood bags containing billions of white blood cells, in one hour.

Akadeum’s patented microbubble technology uses low-density particles to float targeted cells to the top of a sample. In addition to reducing the time necessary to produce leukopaks, the technology is also designed to promote the health and physiology of the
cells, allow for minimal handling, increase throughput, and enable less pre-processing.

Akadeum Life Sciences

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.